Changes in Breast 3D Ultrasound Measurements Using Toremifene

Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

20 women were participated to this trial.

Inclusion Criteria:

• age 25-45 healthy person
• regular menstrual cycles
• safe contraception(for example sterilization or condom)

Exclusion Criteria:

• gynecological or other type of cancer
• hormonal contraception
• pregnancy